We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

The Impact of Rosiglitazone on Regression of Atherosclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00166803
Recruitment Status : Suspended (no fund)
First Posted : September 14, 2005
Last Update Posted : January 5, 2009
National Science Council, Taiwan
Information provided by:
National Taiwan University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : November 2008
  Study Completion Date : No date given